Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $70.54 USD
Change Today -0.93 / -1.30%
Volume 1.0M
IDXX On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 5:20 PM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

idexx laboratories inc (IDXX) Snapshot

Open
$69.94
Previous Close
$71.47
Day High
$71.41
Day Low
$69.46
52 Week High
01/23/15 - $84.26
52 Week Low
09/23/14 - $56.75
Market Cap
6.5B
Average Volume 10 Days
635.5K
EPS TTM
$1.97
Shares Outstanding
92.0M
EX-Date
--
P/E TM
35.8x
Dividend
--
Dividend Yield
--
Current Stock Chart for IDEXX LABORATORIES INC (IDXX)

idexx laboratories inc (IDXX) Related Bloomberg News

View More Bloomberg News

idexx laboratories inc (IDXX) Related Businessweek News

No Related Businessweek News Found

idexx laboratories inc (IDXX) Details

IDEXX Laboratories, Inc., together with its subsidiaries, develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, water testing, and dairy markets worldwide. It operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other segments. The company provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assays; veterinary reference laboratory diagnostic and consulting services; practice management systems and services, and digital imaging systems for veterinarians; and biological materials testing and laboratory animal diagnostic instruments and services for biomedical research community. It also offers diagnostic, health-monitoring, and food safety testing products for livestock, poultry, and dairy; products that test water for certain microbiological contaminants; and point-of-care electrolytes and blood gas analyzers that are used in the human point-of-care medical diagnostics market. The company sells its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was founded in 1983 and is headquartered in Westbrook, Maine.

6,400 Employees
Last Reported Date: 02/17/15
Founded in 1983

idexx laboratories inc (IDXX) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $800.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $496.2K
Executive Vice President
Total Annual Compensation: $416.9K
Executive Vice President
Total Annual Compensation: $416.9K
Executive Vice President
Total Annual Compensation: $416.9K
Compensation as of Fiscal Year 2014.

idexx laboratories inc (IDXX) Key Developments

IDEXX Laboratories, Inc. Announces Kidney Function Test, Symmetric Dimethylarginine or SDMA

IDEXX Laboratories, Inc. announced that a kidney function test, called symmetric dimethylarginine or SDMA, will now be automatically included in all routine chemistry panels from IDEXX Reference Laboratories in Canada at no additional cost and with the same rapid turnaround time as routine chemistry panels. This new renal biomarker identifies the onset of kidney disease months or even years earlier than traditional methods, greatly expanding clinical insights and treatment options in cats and dogs. The test arrives on the market after several years of research and clinical studies, culminating in 27 peer-reviewed articles to date and following an extensive pilot launch involving over 600 veterinary practices in the U.S. and Canada in which more than 50,000 SDMA tests were successfully run and used to diagnose potential kidney disease. SDMA was launched in the U.S. in early July, and since that time, over 9,000 clinics have submitted more than 200,000 specimens to IDEXX Reference Laboratories for SDMA testing. Chronic kidney disease (CKD) is a cause of suffering and death in cats and dogs. The results from the submitted specimens are consistent with generally accepted kidney disease prevalence data showing that 1 in 3 cats1 and 1 in 10 dogs2 tested demonstrate some form of kidney disease over their lifetime. Veterinary practitioners are already realizing tremendous benefits from the SDMA test. Until now, kidney disease has been routinely diagnosed in part by measuring blood creatinine. However, creatinine is limited in that it cannot detect kidney disease until late in the disease process, and it is known to have poor sensitivity in pets with low muscle mass. Traditionally, a diagnosis is made when 75% of kidney function has been irreversibly lost. At this point, the prognosis is usually very poor. In recent clinical studies at Texas A&M University and Oregon State University, research revealed that SDMA identified disease much earlier in the disease progression, when the kidneys had suffered far less damage.

IDEXX Laboratories, Inc. - Analyst/Investor Day

To discuss growth strategies in IDEXX's Companion Animal Group and host a question and answer session

IDEXX Laboratories, Inc. - Analyst/Investor Day

To discuss the overall companion animal diagnostic market, the company's long-term growth strategy and to provide company's financial overview

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IDXX:US $70.54 USD -0.93

IDXX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
DENTSPLY International Inc $50.74 USD -1.67
MEDNAX Inc $78.26 USD -2.29
ResMed Inc $50.75 USD -1.19
Teleflex Inc $126.55 USD -4.25
Cooper Cos Inc/The $159.41 USD -3.01
View Industry Companies
 

Industry Analysis

IDXX

Industry Average

Valuation IDXX Industry Range
Price/Earnings 18.6x
Price/Sales 4.5x
Price/Book 800.9x
Price/Cash Flow 37.1x
TEV/Sales 3.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IDEXX LABORATORIES INC, please visit www.idexx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.